Position in DYN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$33,068,845
+$31,561,390 QoQ
Shares Held
1,488,917
+1690.7% QoQ
Ownership
0.797%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#34
of 245 holders
Holding Since
Jun 2021
18 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in DYN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MARSHALL WACE, LLP holds $3,014,740,742 across 267 Biotechnology names. DYN ranks #29 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
543,897 | $270,169,956 | |
| 2 | INCY |
Incyte Corp
|
1,310,154 | $148,519,056 | |
| 3 | RPRX |
Royalty Pharma plc
|
2,450,669 | $137,409,009 | |
| 4 | SYRE |
Spyre Therapeutics, Inc.
|
991,693 | $88,042,503 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
259,799 | $78,207,292 | |
| 6 | TVTX |
Travere Therapeutics, Inc.
|
1,333,207 | $75,739,488 | |
| 7 | MANE |
Veradermics, Inc
|
585,560 | $71,988,746 | |
| 8 | DFTX |
Definium Therapeutics, Inc.
|
1,298,946 | $61,102,419 |
All Filings in DYN
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $33,068,845 | 1,488,917 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $1,507,455 | 83,147 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $13,241,708 | 676,979 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $38,119,219 | 3,013,377 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $4,263,122 | 447,807 | Shares | Other | 2025-08-13 | |
| 2024-12-31 | $577,243 | 24,501 | Shares | Other | 2025-02-13 | |
| 2024-06-30 | $9,654,179 | 273,567 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $1,524,684 | 53,705 | Shares | Other | 2024-05-15 | |
| 2023-09-30 | $197,585 | 22,052 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $248,085 | 22,052 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $1,524,602 | 132,344 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $255,582 | 22,052 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $824,357 | 64,910 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $2,399,546 | 349,279 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $3,367,049 | 349,279 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $4,152,927 | 349,279 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $358,124 | 22,052 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $463,974 | 22,052 | Shares | Sole | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||